Page last updated: 2024-10-24

carvedilol and Arrhythmia

carvedilol has been researched along with Arrhythmia in 43 studies

Research Excerpts

ExcerptRelevanceReference
"To investigate the effect of low-dose carvedilol combined with candesartan in the prevention of acute and chronic cardiotoxicity of anthracycline drugs in adjuvant chemotherapy of breast cancer."9.17[Preventive effect of low-dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer]. ( Han, YL; Liang, XF; Liu, L; Liu, YY; Liu, ZZ; Xie, XD; Zheng, ZD, 2013)
"To investigate the effects of carvedilol and metoprolol on the expression of autoantibodies against cardiac β(1), β(2) and α(1) adrenergic receptors in aged patients with chronic heart failure (CHF) and ventricular arrhythmia (VA)."9.14[Effects of carvedilol and metoprolol on expression of autoantibodies against cardiac adrenergic receptors in aged patients with chronic heart failure and ventricular arrhythmia]. ( Li, XD; Wang, JC; Ye, L; Zhao, Y; Zhou, NN; Zhu, X, 2010)
"The aim of this study was investigate the effects of carvedilol therapy on ventricular repolarization characteristics as assessed by QT dispersion (QTd) and heart rate variability (HRV) in patients with heart failure."9.12Effects of carvedilol therapy on arrhythmia markers in patients with congestive heart failure. ( Akdeniz, B; Aslan, O; Badak, O; Baris, N; Göldeli, O; Guneri, S; Kirimli, O; Savas, IZ, 2006)
"Carvedilol is a nonselective beta-blocker with alpha-mediated vasodilating properties that has been shown to be effective in systemic hypertension, stable angina, and congestive heart failure (CHF)."9.07Effects of carvedilol on ventricular arrhythmias. ( DasGupta, P; Lahiri, A; Müller-Beckmann, B; Senior, R; van der Does, R, 1992)
" However, limited data exist regarding the effects of the beta-blocker (BB) carvedilol on arrhythmia and urologic outcomes in BPH patients."8.31Effects of the beta-blocker carvedilol on arrhythmia and long-term clinical outcomes in benign prostate hypertrophy patients. ( Heo, JH; Im, SI; Kang, PM; Kim, BJ; Kim, HS; Kim, SJ; Kim, TS; Park, HS, 2023)
"We identified that carvedilol, a β-blocker not commonly used in HCM, suppresses contractile function and arrhythmia by inhibiting RyR2 (ryanodine receptor type 2)."8.31Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol. ( Ashley, EA; Bernstein, D; Huang, Y; Kawana, M; Kirillova, A; Lane, KV; Parikh, VN; Perez, MV; Pruitt, BL; Seo, K; Wang, Q; Wheeler, MT; Wu, JC; Yadav, S; Yamamoto, Y, 2023)
"This study evaluates the impact of carvedilol dose changes on the ventricular arrhythmia event rates for patients > 18 years of age with systolic heart failure and examines dose dependent effects of carvedilol withdrawal in dose reduction and discontinuation subgroups."7.81Dose Related Patterns of Ventricular Arrhythmia due to Carvedilol Withdrawal in Patients with Systolic Heart Failure. ( Anaya, P; Brouse, SD; Charnigo, RJ; Kido, K; Macaulay, TE, 2015)
"We conclude that the addition of carvedilol to standard therapy can improve clinical symptoms and heart rate variability, and reduce in arrhythmia markers in children with DCM."7.79Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy. ( Akdeniz, C; Balli, S; Ece, I; Kibar, AE; Oflaz, MB; Tuzcu, V, 2013)
"We hypothesized that carvedilol, a nonselective β-blocker, can exert antiarrhythmogenic effects by inhibiting sympathetic nerve sprouting and electrical remodeling at peri-infarct zones after myocardial infarction (MI)."7.76Carvedilol ameliorates sympathetic nerve sprouting and electrical remodeling after myocardial infarction in rats. ( He, B; Hu, X; Huang, C; Jiang, H; Lu, Z; Tang, Q; Wen, H, 2010)
"These results indicate that carvedilol has the inhibitory effect against reperfusion arrhythmias in rats and suggest that the mechanism of action of this compound is related to the combined effects of beta-blocking and antioxidant."7.70The inhibitory effects of carvedilol against arrhythmias induced by coronary reperfusion in anesthetized rats. ( Ijiri, H; Ishihara, T; Kohno, I; Komori, S; Matsumura, K; Osada, M; Sawanobori, T; Takusagawa, M; Tamura, K; Umetani, K, 2000)
"Ventricular and atrial arrhythmias are common after acute myocardial infarction (AMI) and are associated with a poor prognosis."6.71Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. ( Colucci, W; Dargie, H; Ford, I; Køber, L; Lopez-Sendon, J; McMurray, J; Remme, W; Robertson, M; Sharpe, DN, 2005)
"Carvedilol is a beta- and alpha-adrenergic-blocking drug with clinically important antiarrhythmic properties."6.43Carvedilol's antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction. ( Lukas, MA; Naccarelli, GV, 2005)
"To investigate the effect of low-dose carvedilol combined with candesartan in the prevention of acute and chronic cardiotoxicity of anthracycline drugs in adjuvant chemotherapy of breast cancer."5.17[Preventive effect of low-dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer]. ( Han, YL; Liang, XF; Liu, L; Liu, YY; Liu, ZZ; Xie, XD; Zheng, ZD, 2013)
"To investigate the effects of carvedilol and metoprolol on the expression of autoantibodies against cardiac β(1), β(2) and α(1) adrenergic receptors in aged patients with chronic heart failure (CHF) and ventricular arrhythmia (VA)."5.14[Effects of carvedilol and metoprolol on expression of autoantibodies against cardiac adrenergic receptors in aged patients with chronic heart failure and ventricular arrhythmia]. ( Li, XD; Wang, JC; Ye, L; Zhao, Y; Zhou, NN; Zhu, X, 2010)
"The aim of this study was investigate the effects of carvedilol therapy on ventricular repolarization characteristics as assessed by QT dispersion (QTd) and heart rate variability (HRV) in patients with heart failure."5.12Effects of carvedilol therapy on arrhythmia markers in patients with congestive heart failure. ( Akdeniz, B; Aslan, O; Badak, O; Baris, N; Göldeli, O; Guneri, S; Kirimli, O; Savas, IZ, 2006)
"Carvedilol is a nonselective beta-blocker with alpha-mediated vasodilating properties that has been shown to be effective in systemic hypertension, stable angina, and congestive heart failure (CHF)."5.07Effects of carvedilol on ventricular arrhythmias. ( DasGupta, P; Lahiri, A; Müller-Beckmann, B; Senior, R; van der Does, R, 1992)
"Carvedilol is an adrenergic antagonist with nonselective beta- and a1-receptor blocking properties that has demonstrated significant clinical benefit in the management of patients with heart failure and in the post-myocardial infarction setting."4.82Carvedilol: beta-blockade and beyond. ( Gheorghiade, M; Stroe, AF, 2004)
" However, limited data exist regarding the effects of the beta-blocker (BB) carvedilol on arrhythmia and urologic outcomes in BPH patients."4.31Effects of the beta-blocker carvedilol on arrhythmia and long-term clinical outcomes in benign prostate hypertrophy patients. ( Heo, JH; Im, SI; Kang, PM; Kim, BJ; Kim, HS; Kim, SJ; Kim, TS; Park, HS, 2023)
"We identified that carvedilol, a β-blocker not commonly used in HCM, suppresses contractile function and arrhythmia by inhibiting RyR2 (ryanodine receptor type 2)."4.31Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol. ( Ashley, EA; Bernstein, D; Huang, Y; Kawana, M; Kirillova, A; Lane, KV; Parikh, VN; Perez, MV; Pruitt, BL; Seo, K; Wang, Q; Wheeler, MT; Wu, JC; Yadav, S; Yamamoto, Y, 2023)
"This study evaluates the impact of carvedilol dose changes on the ventricular arrhythmia event rates for patients > 18 years of age with systolic heart failure and examines dose dependent effects of carvedilol withdrawal in dose reduction and discontinuation subgroups."3.81Dose Related Patterns of Ventricular Arrhythmia due to Carvedilol Withdrawal in Patients with Systolic Heart Failure. ( Anaya, P; Brouse, SD; Charnigo, RJ; Kido, K; Macaulay, TE, 2015)
"We conclude that the addition of carvedilol to standard therapy can improve clinical symptoms and heart rate variability, and reduce in arrhythmia markers in children with DCM."3.79Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy. ( Akdeniz, C; Balli, S; Ece, I; Kibar, AE; Oflaz, MB; Tuzcu, V, 2013)
"Carvedilol is one of the most effective beta blockers for preventing ventricular tachyarrhythmias in heart failure, but the mechanisms underlying its favorable antiarrhythmic benefits remain unclear."3.77Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release. ( Back, TG; Chen, H; Chen, J; Chen, SR; Chen, W; Cheng, H; Duff, HJ; Feldman, AM; Fill, M; Gillis, AM; Guo, A; Jiang, D; Jones, PP; Li, X; Smith, CD; Song, LS; Tian, X; Vembaiyan, K; Wang, A; Wang, R; Xiao, J; Xie, C; Yang, D; Zhang, J; Zhang, L; Zhong, X; Zhou, Q; Zhu, W, 2011)
"We hypothesized that carvedilol, a nonselective β-blocker, can exert antiarrhythmogenic effects by inhibiting sympathetic nerve sprouting and electrical remodeling at peri-infarct zones after myocardial infarction (MI)."3.76Carvedilol ameliorates sympathetic nerve sprouting and electrical remodeling after myocardial infarction in rats. ( He, B; Hu, X; Huang, C; Jiang, H; Lu, Z; Tang, Q; Wen, H, 2010)
"Baroreflex sensitivity was assessed in 287 patients with history of myocardial infarction and left ventricular ejection fraction < or =40% by phenylephrine test and was found to be depressed (4."3.72[Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction]. ( Bozhko, AA; Kanopskiĭ, SG; Staritskiĭ, AG, 2004)
"These results indicate that carvedilol has the inhibitory effect against reperfusion arrhythmias in rats and suggest that the mechanism of action of this compound is related to the combined effects of beta-blocking and antioxidant."3.70The inhibitory effects of carvedilol against arrhythmias induced by coronary reperfusion in anesthetized rats. ( Ijiri, H; Ishihara, T; Kohno, I; Komori, S; Matsumura, K; Osada, M; Sawanobori, T; Takusagawa, M; Tamura, K; Umetani, K, 2000)
"Ventricular and atrial arrhythmias are common after acute myocardial infarction (AMI) and are associated with a poor prognosis."2.71Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. ( Colucci, W; Dargie, H; Ford, I; Køber, L; Lopez-Sendon, J; McMurray, J; Remme, W; Robertson, M; Sharpe, DN, 2005)
"Carvedilol is a non-selective β-blocker with α₁-adrenergic receptor antagonism properties."2.48A critical review of the use of carvedilol in ischemic heart disease. ( Abrencillo, R; Chen-Scarabelli, C; Di Rezze, J; Faggian, G; Gardin, T; Gidwani, UK; Murad, Y; Qureshi, W; Saravolatz, L; Scarabelli, TM; Shieh, WS, 2012)
"Carvedilol is a beta- and alpha-adrenergic-blocking drug with clinically important antiarrhythmic properties."2.43Carvedilol's antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction. ( Lukas, MA; Naccarelli, GV, 2005)
" Carvedilol can be added to Amiodarone in patients with severe ventricular rhythm disorders and increased risk of sudden death without expecting of increase adverse events (than either drug alone) or loss of clinical efficacy."1.46THE SAFETY AND EFFICACY OF AMIODARONE AND CARVEDILOL COMBINATION IN TREATMENT OF PATIENTS WITH SEVERE CARDIAC RHYTHM DISORDERS. ( Khintibidze, I; Tsetskhladze, E, 2017)
" Beta-blocker dosages were titrated, and three patients achieved the target beta-blocker dosage established for stage A-C heart failure."1.34Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone. ( Earl, GL; Fitzpatrick, JM; Narula, J; Verbos-Kazanas, MA, 2007)

Research

Studies (43)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (6.98)18.2507
2000's21 (48.84)29.6817
2010's14 (32.56)24.3611
2020's5 (11.63)2.80

Authors

AuthorsStudies
Jia, L1
Sun, H1
Groszek, G1
Bednarski, M1
Dybała, M1
Filipek, B2
Szkaradek, N1
Rapacz, A1
Pytka, K1
Siwek, A1
Cegła, M1
Marona, H1
Vivier, D1
Bennis, K1
Lesage, F1
Ducki, S1
Robinson, VM1
Alsalahat, I1
Freeman, S1
Antzelevitch, C1
Barajas-Martinez, H1
Venetucci, L1
Kim, SJ1
Park, HS1
Kang, PM1
Kim, BJ1
Kim, HS1
Heo, JH1
Kim, TS1
Im, SI1
Seo, K1
Yamamoto, Y1
Kirillova, A1
Kawana, M1
Yadav, S1
Huang, Y1
Wang, Q1
Lane, KV1
Pruitt, BL1
Perez, MV1
Bernstein, D1
Wu, JC1
Wheeler, MT1
Parikh, VN1
Ashley, EA1
Muhailan, M1
Al-Shbool, G1
Zhang, JG1
Dai, SP1
Liu, H1
Xu, ZS1
Tsetskhladze, E1
Khintibidze, I1
Oflaz, MB1
Balli, S1
Kibar, AE1
Ece, I1
Akdeniz, C1
Tuzcu, V1
Bodi, I1
Franke, G1
Pantulu, ND1
Wu, K1
Perez-Feliz, S1
Bode, C1
Zehender, M1
zur Hausen, A1
Brunner, M1
Odening, KE1
Liu, L1
Liu, ZZ1
Liu, YY1
Zheng, ZD1
Liang, XF1
Han, YL1
Xie, XD1
Kido, K1
Brouse, SD1
Macaulay, TE1
Charnigo, RJ1
Anaya, P1
Motoki, N1
Inaba, Y1
Matsuzaki, S1
Akazawa, Y1
Nishimura, T1
Fukuyama, T1
Koike, K1
Tan, Z1
Xiao, Z1
Wei, J1
Zhang, J2
Zhou, Q2
Smith, CD2
Nani, A1
Wu, G1
Song, LS2
Back, TG2
Fill, M2
Chen, SR2
Wen, H1
Jiang, H1
Lu, Z1
Hu, X1
He, B1
Tang, Q1
Huang, C1
Li, XD1
Wang, JC1
Ye, L1
Zhao, Y1
Zhou, NN1
Zhu, X1
Xiao, J1
Jiang, D1
Wang, R1
Vembaiyan, K1
Wang, A1
Xie, C1
Chen, W1
Tian, X1
Jones, PP1
Zhong, X1
Guo, A1
Chen, H1
Zhang, L1
Zhu, W1
Yang, D1
Li, X1
Chen, J1
Gillis, AM1
Duff, HJ1
Cheng, H1
Feldman, AM1
Knollmann, BC1
Chen-Scarabelli, C1
Saravolatz, L2
Murad, Y1
Shieh, WS1
Qureshi, W1
Di Rezze, J1
Abrencillo, R1
Gardin, T1
Gidwani, UK1
Faggian, G1
Scarabelli, TM1
Piccirillo, G1
Quaglione, R1
Nocco, M1
Naso, C1
Moisè, A1
Lionetti, M1
Di Carlo, S1
Marigliano, V1
Coca, SG1
Buller, GK1
Liebson, PR1
Stroe, AF1
Gheorghiade, M1
Kanopskiĭ, SG1
Staritskiĭ, AG1
Bozhko, AA1
Anh, D1
Marine, JE1
McMurray, J1
Køber, L1
Robertson, M1
Dargie, H1
Colucci, W1
Lopez-Sendon, J1
Remme, W1
Sharpe, DN1
Ford, I1
Pratt, CM1
Naccarelli, GV2
Lukas, MA1
El-Sherif, N1
Turitto, G1
Akdeniz, B1
Guneri, S1
Savas, IZ1
Aslan, O1
Baris, N1
Badak, O1
Kirimli, O1
Göldeli, O1
Earl, GL1
Verbos-Kazanas, MA1
Fitzpatrick, JM1
Narula, J1
Fox, K1
Borer, JS1
Camm, AJ1
Danchin, N1
Ferrari, R1
Lopez Sendon, JL1
Steg, PG1
Tardif, JC1
Tavazzi, L1
Tendera, M1
Fett, JD1
Witte, KK1
Clark, AL1
Taylor, SH1
Storstein, L2
Fauchier, L1
Giraudeau, B1
Takusagawa, M1
Komori, S1
Matsumura, K1
Osada, M1
Kohno, I1
Umetani, K1
Ishihara, T1
Sawanobori, T1
Ijiri, H1
Tamura, K1
Vasil'ev, AP1
Strel'tsova, NN1
Gorbunova, TIu1
Mal'tseva, IA1
Zykova, EL1
Senior, R1
Müller-Beckmann, B1
DasGupta, P1
van der Does, R1
Lahiri, A1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Single Centre, Retrospective Cohort Study on Post Analysis on the Link Between the Clinical Heart Rate and Outcomes During PCI[NCT02351674]15,000 participants (Anticipated)Observational2015-01-31Not yet recruiting
Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286]Phase 440 participants (Actual)Interventional2009-05-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

9 reviews available for carvedilol and Arrhythmia

ArticleYear
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
    Journal of medicinal chemistry, 2016, 06-09, Volume: 59, Issue:11

    Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Struc

2016
A critical review of the use of carvedilol in ischemic heart disease.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2012, Dec-01, Volume: 12, Issue:6

    Topics: Adrenergic beta-Antagonists; Angina, Stable; Animals; Anti-Arrhythmia Agents; Antioxidants; Arrhythm

2012
Carvedilol: beta-blockade and beyond.
    Reviews in cardiovascular medicine, 2004, Volume: 5 Suppl 1

    Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carbazoles; Carvedilol; Clinical Trials as Topic;

2004
Beta blockers as anti-arrhythmic agents.
    Heart failure reviews, 2004, Volume: 9, Issue:2

    Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Carbazoles; Carvedilol; H

2004
Carvedilol's antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction.
    Clinical cardiology, 2005, Volume: 28, Issue:4

    Topics: Adrenergic alpha-Antagonists; Arrhythmias, Cardiac; Carbazoles; Carvedilol; Electrocardiography; Hea

2005
Electrophysiologic effects of carvedilol: is carvedilol an antiarrhythmic agent?
    Pacing and clinical electrophysiology : PACE, 2005, Volume: 28, Issue:9

    Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Antioxidants; Arrhy

2005
Resting heart rate in cardiovascular disease.
    Journal of the American College of Cardiology, 2007, Aug-28, Volume: 50, Issue:9

    Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Carbazoles; Ca

2007
Resting heart rate in cardiovascular disease.
    Journal of the American College of Cardiology, 2007, Aug-28, Volume: 50, Issue:9

    Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Carbazoles; Ca

2007
Resting heart rate in cardiovascular disease.
    Journal of the American College of Cardiology, 2007, Aug-28, Volume: 50, Issue:9

    Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Carbazoles; Ca

2007
Resting heart rate in cardiovascular disease.
    Journal of the American College of Cardiology, 2007, Aug-28, Volume: 50, Issue:9

    Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Carbazoles; Ca

2007
Carvedilol in the treatment of elderly patients with chronic heart failure.
    Clinical interventions in aging, 2008, Volume: 3, Issue:1

    Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; C

2008
Carvedilol--clinical experience in arrhythmias.
    Cardiology, 1993, Volume: 82 Suppl 3

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias,

1993

Trials

8 trials available for carvedilol and Arrhythmia

ArticleYear
[Preventive effect of low-dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2013, Volume: 35, Issue:12

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antineoplastic Co

2013
[Effects of carvedilol and metoprolol on expression of autoantibodies against cardiac adrenergic receptors in aged patients with chronic heart failure and ventricular arrhythmia].
    Zhonghua xin xue guan bing za zhi, 2010, Volume: 38, Issue:7

    Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Autoantibodies; Carbazoles; Carvedilol; Female; Heart

2010
Effects of long-term beta-blocker (metoprolol or carvedilol) therapy on QT variability in subjects with chronic heart failure secondary to ischemic cardiomyopathy.
    The American journal of cardiology, 2002, Nov-15, Volume: 90, Issue:10

    Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carbazoles; Carvedilol; Female; Heart Failure; Hu

2002
Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.
    Journal of the American College of Cardiology, 2005, Feb-15, Volume: 45, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Carbazoles; Carve

2005
Does carvedilol have antiarrhythmic properties?
    Nature clinical practice. Cardiovascular medicine, 2005, Volume: 2, Issue:7

    Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carbazoles; Carvedilol; Follow-Up Studies; Humans

2005
Effects of carvedilol therapy on arrhythmia markers in patients with congestive heart failure.
    International heart journal, 2006, Volume: 47, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Carbazoles; Carve

2006
[Antioxidant and antiarrhythmic activity of carvedilol in patients with ischemic heart disease. Comparison with anaprilin].
    Terapevticheskii arkhiv, 2001, Volume: 73, Issue:10

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Antioxidants; Arrhythmias, Car

2001
Effects of carvedilol on ventricular arrhythmias.
    Journal of cardiovascular pharmacology, 1992, Volume: 19 Suppl 1

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Carbazoles; Carv

1992

Other Studies

26 other studies available for carvedilol and Arrhythmia

ArticleYear
Support vector machines classification of hERG liabilities based on atom types.
    Bioorganic & medicinal chemistry, 2008, Jun-01, Volume: 16, Issue:11

    Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant

2008
Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol and its enantiomers. Part 1.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:2

    Topics: 2-Propanol; Adrenergic Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electroca

2009
Synthesis and preliminary evaluation of pharmacological properties of some piperazine derivatives of xanthone.
    Bioorganic & medicinal chemistry, 2013, Jan-15, Volume: 21, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Heart Rate; Male; Piperazine;

2013
A carvedilol analogue, VK-II-86, prevents hypokalaemia-induced ventricular arrhythmia through novel multi-channel effects.
    British journal of pharmacology, 2022, Volume: 179, Issue:11

    Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium; Carvedilol; Dantrolene; Dogs; HEK293 Cell

2022
Effects of the beta-blocker carvedilol on arrhythmia and long-term clinical outcomes in benign prostate hypertrophy patients.
    Medicine, 2023, Sep-08, Volume: 102, Issue:36

    Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carvedilol; Humans; Hypertrophy; Male; Prostate;

2023
Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol.
    Circulation, 2023, Nov-21, Volume: 148, Issue:21

    Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Carvedilol

2023
Pseudo-Wellens' Syndrome Temporally Associated With Immune Check Point Inhibitors Use.
    The American journal of the medical sciences, 2020, Volume: 359, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Antineoplast

2020
Comparison of carvedilol versus metoprolol in patients with acute myocardial infarction: A protocol for systematic review and meta-analysis.
    Medicine, 2021, May-21, Volume: 100, Issue:20

    Topics: Arrhythmias, Cardiac; Carvedilol; Death, Sudden, Cardiac; Humans; Meta-Analysis as Topic; Metoprolol

2021
THE SAFETY AND EFFICACY OF AMIODARONE AND CARVEDILOL COMBINATION IN TREATMENT OF PATIENTS WITH SEVERE CARDIAC RHYTHM DISORDERS.
    Georgian medical news, 2017, Issue:267

    Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibril

2017
Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy.
    Medical science monitor : international medical journal of experimental and clinical research, 2013, May-15, Volume: 19

    Topics: Arrhythmias, Cardiac; Autonomic Nervous System; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Chi

2013
Differential effects of the β-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels.
    Journal of cardiovascular electrophysiology, 2013, Volume: 24, Issue:10

    Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Carbazoles; Carvedilo

2013
Dose Related Patterns of Ventricular Arrhythmia due to Carvedilol Withdrawal in Patients with Systolic Heart Failure.
    Current drug safety, 2015, Volume: 10, Issue:3

    Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Carbazoles; Carvedilol; Dose-Response Relat

2015
Successful treatment of arrhythmia-induced cardiomyopathy in an infant with tuberous sclerosis complex.
    BMC pediatrics, 2016, Jan-25, Volume: 16

    Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carbazoles; Cardiomyopathy, Dilated; Carvedilol;

2016
Nebivolol suppresses cardiac ryanodine receptor-mediated spontaneous Ca2+ release and catecholaminergic polymorphic ventricular tachycardia.
    The Biochemical journal, 2016, Nov-15, Volume: 473, Issue:22

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Cal

2016
Carvedilol ameliorates sympathetic nerve sprouting and electrical remodeling after myocardial infarction in rats.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2010, Volume: 64, Issue:7

    Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Autonomic Pathways; C

2010
Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release.
    Nature medicine, 2011, Jul-10, Volume: 17, Issue:8

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bisoprolol; Calcium; Calci

2011
Carvedilol tweaks calcium release to ease arrhythmias.
    Nature medicine, 2011, Aug-04, Volume: 17, Issue:8

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Calcium Channel Blockers; Carbazoles

2011
COMET: a proposed mechanism of action to explain the results and concerns about dose.
    Lancet (London, England), 2003, Sep-27, Volume: 362, Issue:9389

    Topics: Adenosine Triphosphatases; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carbazoles; Carvedilol

2003
AVID and COMET.
    Preventive cardiology, 2003,Fall, Volume: 6, Issue:4

    Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carbazoles; Carvedilol; Heart Conduction System;

2003
[Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
    Kardiologiia, 2004, Volume: 44, Issue:10

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti

2004
Three decades of clinical trials with beta-blockers: the contribution of the CAPRICORN trial and the effect of carvedilol on serious arrhythmias.
    Journal of the American College of Cardiology, 2005, Feb-15, Volume: 45, Issue:4

    Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carbazoles; Carvedilol; Clinical Trials as Topic;

2005
Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
    Pharmacotherapy, 2007, Volume: 27, Issue:5

    Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Blood Pressure; Carbazoles; Cardiac Output,

2007
Case 36-2007: a woman with rash, fever, and hypotension.
    The New England journal of medicine, 2008, Mar-27, Volume: 358, Issue:13

    Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carbazoles; Carvedilol; Female; Humans; Hypotensi

2008
Carvedilol--a wide therapeutic potential in cardiovascular syndromes. Introduction.
    Cardiology, 1993, Volume: 82 Suppl 3

    Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carbazoles; Carvedilol; Free Radical Scavengers;

1993
Beta-blockers and ventricular arrhythmias in dilated cardiomyopathy.
    Journal of the American College of Cardiology, 2000, Volume: 35, Issue:7

    Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carbazoles; Cardiomyopathy, Dilated; Carvedilol;

2000
The inhibitory effects of carvedilol against arrhythmias induced by coronary reperfusion in anesthetized rats.
    Journal of cardiovascular pharmacology and therapeutics, 2000, Volume: 5, Issue:2

    Topics: Adrenergic beta-Antagonists; Anesthesia, General; Animals; Arrhythmias, Cardiac; Carbazoles; Carvedi

2000